|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 190.2 INR | -0.05% |
|
+0.11% | -8.17% |
| May. 09 | Transcript : Nath Bio-Genes Limited, Q4 2024 Earnings Call, May 09, 2024 | |
| May. 08 | Nath Bio-Genes Limited Recommends Dividend for Financial Year 2023-24 | CI |
Nath Bio-Genes (India) Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 3,326.25 million compared to INR 3,013.64 million a year ago. Revenue was INR 3,326.25 million compared to INR 3,013.64 million a year ago.
Net income was INR 396.19 million compared to INR 350.11 million a year ago. Basic earnings per share was INR 21.34 compared to INR 18.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.17% | 43.43M | |
| +12.78% | 3.34B | |
| -95.58% | 1.61B | |
| -2.44% | 1.57B | |
| +0.66% | 1.35B | |
| -1.25% | 1.27B | |
| -.--% | 1.24B | |
| +3.34% | 1.21B | |
| -11.54% | 1.23B | |
| 0.00% | 1.2B |
NATH BIO-GENES (INDIA) LIMITED 
